STOCK TITAN

EverQuote CEO Mendal exercises $6.96 options, sells

The November 2 option exercise and sales were under a Rule 10b5-1 plan adopted June 16, 2026; the November 4 exercise was outside that plan.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

EverQuote, Inc. (EVER) CEO and President Jayme Mendal exercised options for 11,406 shares at $6.96 per share on November 2, 2026, and sold 18,157 shares at a weighted average $23.82 and 2,824 shares at a weighted average $24.27. The November 2 option exercise and sales were under a Rule 10b5-1 plan adopted June 16, 2026. On November 4, he exercised options for 28,725 shares at $6.96, paid the exercise price in cash, and retained all shares acquired; that exercise was outside the plan.

Insider Mendal Jayme
Role CEO and President
Sold 20,981 shs ($501K)
Approx. gross sale proceeds $501K
Approx. exercise cost $279K
Type Security Shares Price Value
Exercise Stock Option (right to buy) F4, F5 28,725 $6.96 $200K
Exercise Class A Common Stock F4 28,725 $0.00 $0.00
Exercise Stock Option (right to buy) F1, F5 11,406 $6.96 $79K
Exercise Class A Common Stock F1 11,406 $0.00 $0.00
Sale Class A Common Stock F1, F2 18,157 $23.82 $432K
Sale Class A Common Stock F1, F3 2,824 $24.27 $69K
Holdings After Transaction: Stock Option (right to buy) — 62,938 contracts (Direct); Class A Common Stock — 576,978 shares (Direct)
Footnotes (5)
  1. F1. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.22 to $24.21, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.22 to $24.32, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
  4. F4. The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.
  5. F5. This option was granted on October 18, 2017. 25% of the shares underlying the option vested on September 30, 2018, with the remaining shares vesting monthly thereafter over the following three years.
Shares acquired through option exercise 11,406 shares November 2, 2026
Option exercise price $6.96 per share Options exercised November 2 and November 4, 2026
Shares acquired through option exercise 28,725 shares November 4, 2026
Shares sold 18,157 shares November 2, 2026
Weighted average sale price $23.82 per share 18,157 shares sold November 2, 2026
Shares sold 2,824 shares November 2, 2026
Weighted average sale price $24.27 per share 2,824 shares sold November 2, 2026
Rule 10b5-1 trading plan regulatory
"pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (right to buy) financial
"Stock Option (right to buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EVER shares did Jayme Mendal sell, and at what prices?

He sold 18,157 shares at a weighted average price of $23.82, with trades ranging from $23.22 to $24.21, and 2,824 shares at a weighted average price of $24.27, with trades ranging from $24.22 to $24.32. The sales were made under a Rule 10b5-1 plan adopted June 16, 2026.

How many EVER shares did Jayme Mendal acquire through option exercises?

He exercised options for 11,406 shares on November 2, 2026, and for 28,725 shares on November 4, 2026, at $6.96 per share. The November 2 exercise was under the Rule 10b5-1 plan; for the November 4 exercise, he paid the exercise price in cash and retained all shares acquired.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mendal Jayme

(Last)(First)(Middle)
C/O EVERQUOTE, INC.
141 PORTLAND STREET

(Street)
CAMBRIDGE MASSACHUSETTS 02139

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EverQuote, Inc. [ EVER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/02/2026M11,406(1)A$0569,234D
Class A Common Stock11/02/2026S18,157(1)D$23.82(2)551,077D
Class A Common Stock11/02/2026S2,824(1)D$24.27(3)548,253D
Class A Common Stock11/04/2026M28,725(4)A$0576,978D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$6.9611/02/2026M11,406(1) (5)10/17/2027Class A Common Stock11,406$6.9691,663D
Stock Option (right to buy)$6.9611/04/2026M28,725(4) (5)10/17/2027Class A Common Stock28,725$6.9662,938D
Explanation of Responses:
1. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.22 to $24.21, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.22 to $24.32, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
4. The reporting person exercised this option outside of a Rule 10b5-1 trading plan and paid the exercise price in cash. The reporting person continues to hold all shares acquired upon exercise, and no shares were sold or withheld in connection with this exercise.
5. This option was granted on October 18, 2017. 25% of the shares underlying the option vested on September 30, 2018, with the remaining shares vesting monthly thereafter over the following three years.
/s/ Jon Ayotte, as attorney-in-fact for Jayme Mendal11/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading